Market Cap 1.10B
Revenue (ttm) 178.96M
Net Income (ttm) -159.49M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -89.12%
Debt to Equity Ratio 0.00
Volume 2,191,300
Avg Vol 1,846,762
Day's Range N/A - N/A
Shares Out 148.58M
Stochastic %K 44%
Beta 1.53
Analysts Strong Sell
Price Target $9.71

Latest News on ADPT

Top 3 Health Care Stocks That May Collapse This Quarter

Dec 11, 2024, 6:55 AM EST - 4 months ago

Top 3 Health Care Stocks That May Collapse This Quarter

FNA NAMS


Adaptive Biotechnologies: Making Some Progress

Nov 26, 2024, 10:53 AM EST - 4 months ago

Adaptive Biotechnologies: Making Some Progress


Adaptive Announces Launch of Epic Integration for clonoSEQ®

Sep 13, 2023, 7:30 AM EDT - 1 year ago

Adaptive Announces Launch of Epic Integration for clonoSEQ®


Adaptive Biotechnologies: Getting Closer To The 'Buy Zone'

Jul 7, 2023, 2:00 PM EDT - 1 year ago

Adaptive Biotechnologies: Getting Closer To The 'Buy Zone'